Ormat Funding Corp. Announces Launch of Consent Solicitation
Relating to the 8 1/4% Senior Secured Notes due December 30, 2020
CUSIP No.: 686685AB4
RENO, Nev., Dec. 3, 2012 /PRNewswire/ -- Ormat Funding Corp. (the "Company"), a wholly owned subsidiary of Ormat Technologies, Inc. (NYSE: ORA), announced today that it has launched a consent solicitation relating to its 8 1/4% Senior Secured Notes due December 30, 2020 (CUSIP Number: 686685AB4). The record date to determine holders of the Notes eligible to consent is November 21, 2012. The consent solicitation expires at 5:00 p.m., New York time, on December 7, 2012, unless extended by the Company (the "Expiration Date"). The consent solicitation is made upon the terms and subject to the conditions set forth in the Consent Solicitation Statement dated December 3, 2012, which is being mailed to all holders of the Notes.
The consent solicitation is being conducted in order to waive certain provisions in the Indenture governing the Notes. Receipt of valid and not revoked written consents from holders of at least 66% of the aggregate principal amount of outstanding Notes will constitute acceptance of the consent solicitation whereupon the consent and the waivers granted pursuant thereto shall be effective and consents shall no longer be revocable, all as more fully described in the Consent Solicitation Statement. Holders of Notes may withdraw their consent at any time prior to the date on which consents have been delivered and not validly revoked by holders of at least 66% of the aggregate principal amount of the outstanding Notes.
The Company has retained Barclays Capital Inc. as the Solicitation Agent for the consent solicitation. Union Bank, N.A., is the Tabulation and Information Agent for the consent solicitation. Questions regarding the consent solicitation may be directed to the Liability Management Group at Barclays Capital Inc. at 800-438-3242 (toll-free) or 212-528-7581 (collect). Requests for copies of the Consent Solicitation documents may be directed to the Tabulation and Information Agent at 415-273-2518 or the Company at 775-771-6801.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities nor shall there be any solicitation of consent in any state in which such solicitation or the acceptance thereof would be unlawful.
Safe Harbor Statement
Information provided in this press release may contain statements relating to current expectations, estimates, forecasts and projections about future events that are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally relate to Ormat Funding Corp.'s plans, objectives and expectations for future operations and are based upon its management's current estimates and projections of future results or trends. Actual future results may differ materially from those projected as a result of certain risks and uncertainties. For a discussion of such risks and uncertainties, see "Risk Factors" as described in Ormat Technologies, Inc.'s Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 29, 2012 and Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 8, 2012.
These forward-looking statements are made only as of the date hereof, and we undertake no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.
Ormat Funding Corp.
SOURCE Ormat Technologies, Inc.
More by this Source
Ormat Technologies Reports 2013 First Quarter Results
May 07, 2013, 17:26 ET
Ormat Technologies Commences Operation Of 36 MW Geothermal Power Plant In Kenya
May 02, 2013, 17:44 ET
Ormat Signs 20-Year Power Purchase Agreement for its Wild Rose Geothermal Project in Nevada
Apr 29, 2013, 08:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.